Sartorius Stedim Biotech S.A. SDMHF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | 244.47M | 218.28M | |
| Total Depreciation and Amortization | -- | -- | 294.57M | 286.34M | |
| Total Amortization of Deferred Charges | -- | -- | 44.98M | 44.98M | |
| Total Other Non-Cash Items | -- | -- | 125.54M | 144.24M | |
| Change in Net Operating Assets | -- | -- | 146.15M | 252.92M | |
| Cash from Operations | -- | -- | 855.71M | 946.77M | |
| Capital Expenditure | -- | -- | -317.53M | -317.71M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -1.35M | -213.20K | |
| Cash from Investing | -- | -- | -318.88M | -317.93M | |
| Total Debt Issued | -- | -- | 16.60M | 17.30M | |
| Total Debt Repaid | -- | -- | -52.60M | -341.90M | |
| Issuance of Common Stock | -- | -- | 7.00M | 5.90M | |
| Repurchase of Common Stock | -- | -- | -2.00M | -7.90M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -76.15M | -72.22M | |
| Other Financing Activities | -- | -- | -152.00M | -179.30M | |
| Cash from Financing | -- | -- | -275.26M | -619.69M | |
| Foreign Exchange rate Adjustments | -- | -- | -196.10K | 2.24M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -8.30K | 105.20K | |
| Net Change in Cash | -- | -- | 261.36M | 11.49M | |